Monday, March 24, 2008

How to raise those who be not patient of cellule lung cancer to live time?

Blame cellule lung cancer makes a lot of patients often lost an operation to treat an opportunity when diagnose, can lengthen a patient to live only through changing the method such as cure deadline.

Blame cellule lung cancer makes a lot of patients often lost an operation to treat an opportunity when diagnose, can lengthen a patient to live only through changing the method such as cure deadline. From on 70 time have the century, the effect that is not cure of a gleam of of cellule lung cancer is in all the time slow but improving continuously: In always live time from original 2 ~ 5 months, little ground is in climb rise 6 ~ 8 months, 8 ~ …… of 12.3 10 months, months but overall, current a gleam of changes cure curative effect not very satisfactory, in always live time does not exceed 12 months mostly. How does ability break through such bottleneck? Lung cancer scholars put the view to standardization cure and target to cure go up by force by force together.

The target that treats medicaments to appear as second line, 3 lines at first to medicaments, after in advance application obtains right result, people begins a tentative idea to regard a gleam of as cure its. Study discovery changes cure however at the same time target of profess to convinced can not achieve very good clinical curative effect to medicaments, trying to choose to change target of profess to convinced of cure order follow in a continuous line on experiment design then the method to medicaments, utmost will produce its result. This research that the name is FAST-ACT, use be stranded the name of a river in Shaanxi and Henan provinces to replace the Buddhist nun (Teluokai) change cure to regard a gleam of as cure jointly, order follow in a continuous line is used at IIIB/IV patient of Asia of lung cancer of period blame cellule. a week turns test group patient a week rests after cure ends, at the 15th day of profess to convinced be stranded the name of a river in Shaanxi and Henan provinces replaces the Buddhist nun 150mg/ day, successive 2 weeks, the 28th day ends. Every 4 weeks are a period of treatment, successive 6 period of treatment, the name of a river in Shaanxi and Henan provinces of be stranded of profess to convinced lasts to till the disease makes progress,replace the Buddhist nun after the end, or cannot be able to bear or endure suffer noxiousness react. Newest research shows as a result, with contrast group of photograph comparing, the name of a river in Shaanxi and Henan provinces of be stranded of profess to convinced of follow in a continuous line of the order that change cure can lengthen a patient significantly for the Buddhist nun in live without progress time.

FAST-ACT considers to put forward to change cure and target to be used to order follow in a continuous line of cure first, show skin grows first factor suffers depressor of acerbity kinase of body cheese ammonia and follow in a continuous line of order of standardization cure medicaments to use, the foreground in the cure that is not cellule lung cancer in a gleam of is valued. Both of excel of therapeutics of order follow in a continuous line is taken at the same time likelihood and former and OK more continuously action at tumor cell, can exterminate cell of rest period tumour effectively to concern even. Achievement of this one research means target probably to medicaments from curative of second line, 3 lines content is progressively to curative of a gleam of content strides, this one feed rate wants than what scholars forecast fast many. Of course, this does not mean target to will replace a tradition to change cure to medicaments absolutely, contrary both will develop different tumour to kill and wound a mechanism severally, tumor cure of future will be a basis the patient is individual change demand to adopt corresponding treatment plan. Tell from this angle, target crosses cure of a gleam of gradually to medicaments, to changing cure character is blessing not be disaster.

No comments:

Post a Comment